Niitaka (4465) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
20 Jul, 2026Executive summary
Achieved year-over-year revenue and profit growth driven by increased sales of detergents and solid fuels, product price optimization, and contributions from new subsidiaries.
Net sales increased by 16.6% year-over-year to ¥22,739 million for the year ended May 31, 2024.
Operating profit rose 72.6% year-over-year to ¥1,476 million, with operating margin improving by 2.1 points to 6.5%.
Net income attributable to parent increased 25.7% year-over-year, despite the cancellation of a second factory in China.
Financial highlights
Revenue rose 16.6% year-over-year to ¥22,739 million, exceeding plan progress at 101.1%.
Gross profit increased from ¥6,685 million to ¥8,135 million year-over-year.
Earnings per share rose to ¥119.58 from ¥95.13 year-over-year.
Net assets increased to ¥13,385 million, with an equity ratio of 58.9%.
Comprehensive income rose to ¥829 million from ¥613 million year-over-year.
Outlook and guidance
FY2025 revenue forecast is ¥23,500 million (+3.3% year-over-year), with operating profit expected at ¥1,500 million (+1.6%).
Net income forecasted to rise 41.7% to ¥1,000 million, with ROE improving from 5.4% to 7.3%.
Earnings per share forecast is ¥169.39.
Growth expected from increased sales of detergents and health foods, and cost reduction initiatives.
Latest events from Niitaka
- Profits surged nearly 50% year-over-year, with robust outlook and higher dividend forecast.4465
Q1 202520 Jul 2026 - Profits and net income surged on higher sales and cost controls, with dividends raised.4465
Q2 202520 Jul 2026 - Revenue and profit surged on strong detergent sales, cost cuts, and extraordinary gains.4465
Q3 202520 Jul 2026 - Revenue and profit surged on detergent sales and one-offs; FY2026 expects higher sales but lower profit.4465
Q4 202520 Jul 2026 - Profits and margins improved on strong detergent sales and cost controls, but full-year profit forecast lowered.4465
Q1 202620 Jul 2026 - Profit and revenue grew on strong chemical sales and cost control, with guidance raised.4465
Q2 202620 Jul 2026 - Revenue and operating profit rose, but net profit fell on lower extraordinary gains.4465
Q3 202620 Jul 2026 - Profits and dividends rose in FY2026, but FY2027 forecasts lower profits despite higher sales.4465
Q4 202620 Jul 2026